Natus Medical Incorporated 8-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
The
Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported) February 20, 2007
Natus
Medical Incorporated
|
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
|
Delaware
|
|
000-33001
|
|
77-0154833
|
(State
or other jurisdiction of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer Identification
No.)
|
|
|
|
|
|
1501
Industrial Road, San Carlos, California 94070
|
(Address
of principal executive offices) (Zip Code)
|
|
|
|
|
|
Registrant's
telephone number, including area code: (650)
802-0400 |
|
|
|
|
|
Not
applicable
|
(Former
name or former address, if changed since last
report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
ITEM
2.02. Results
of Operations and Financial Condition.
On
February 20, 2007 Natus Medical Incorporated (the “Company”) is issuing a press
release and holding a conference call regarding its financial results for the
fourth quarter and year ended December 31, 2006 and other financial information.
A copy of the press release is furnished as Exhibit 99.1 to this Form
8-K.
The
information in this Form 8-K and the exhibit attached hereto shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the
“Exchange Act”) or otherwise subject to the liabilities of that Section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
ITEM
9.01. FINANCIAL
STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) |
Exhibits. |
|
|
|
|
|
|
|
Exhibit
No. |
Description |
|
|
|
|
|
99.1 |
Press
release of Natus Medical Incorporated dated February 20, 2007 describing
the Company’s results for its fourth quarter and year ended December 31,
2006 and other financial information. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
NATUS
MEDICAL INCORPORATED |
|
|
|
|
Date:
February 20, 2007 |
|
By: |
/s/
Steven J. Murphy |
|
|
|
Steven
J. Murphy |
|
|
|
Vice
President Finance and Chief Financial
Officer |
Index
to Exhibits
|
Exhibit
No. |
Description |
|
|
|
|
99.1 |
Press
release of Natus Medical Incorporated dated February 20, 2007 describing
the Company’s results for its fourth quarter and year ended December 31,
2006 and other financial information. |